XSMO - ETF AI Analysis
Top Page
Invesco S&P SmallCap Momentum ETF (XSMO)
Rating:66Neutral
Price Target:―
Positive Factors
Strong Recent Year-to-Date Performance
The fund has delivered strong gains so far this year, suggesting its momentum-focused strategy has recently worked well for investors.
Top Holdings Showing Solid Momentum
Many of the largest positions, such as ViaSat, ACM Research, Formfactor, and Powell Industries, have posted strong year-to-date gains, helping drive the ETF’s overall results.
Broad Sector Diversification Within Small Caps
Holdings spread across industries like industrials, technology, health care, financials, and consumer sectors help reduce the impact if any one area of the market weakens.
Negative Factors
Short-Term Performance Bumpiness
The fund’s recent one-month return has been slightly negative, showing that its momentum strategy can experience short-term pullbacks even during a strong year.
High U.S. Market Concentration
With almost all assets invested in U.S. companies, investors get little geographic diversification and remain heavily tied to the U.S. economic and market cycle.
Moderate Expense Ratio
The fund’s fee is not especially low for an ETF, which means a noticeable portion of returns goes toward covering ongoing costs.
XSMO vs. SPDR S&P 500 ETF (SPY)
AUM2.89B
RegionNorth America
Expense Ratio0.35%
Beta0.94
IssuerInvesco
Inception DateMar 03, 2005
Dividend Yield0.62%
Asset ClassEquity
Index TrackedS&P SmallCap 600 Momentum Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume340,323
30 Day Avg. Volume276,877
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
102.47Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering115
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
XSMO Summary
The Invesco S&P SmallCap Momentum ETF (XSMO) invests in smaller U.S. companies that have been rising in price, following the S&P SmallCap 600 Momentum Index. It holds a mix of industries like industrials, technology, and health care, with examples including ViaSat and Esco Technologies. Investors might consider XSMO if they want growth potential from small companies and diversification across many sectors, rather than picking individual small-cap stocks. However, because it focuses on smaller, fast-moving companies, the ETF’s price can be more volatile and can go up and down sharply with changes in the stock market.
How much will it cost me?The Invesco S&P SmallCap Momentum ETF (XSMO) has an expense ratio of 0.36%, meaning you’ll pay $3.60 per year for every $1,000 invested. This is slightly higher than average because it tracks a specialized index focused on small-cap stocks with strong price momentum, which requires more active management. Overall, it’s a reasonable cost for a niche strategy targeting potential growth opportunities.
What would affect this ETF?The Invesco S&P SmallCap Momentum ETF (XSMO) could benefit from a strong U.S. economy, as its focus on small-cap companies with price momentum may thrive in periods of economic growth and innovation, particularly in sectors like Industrials and Technology. However, it may face challenges during economic downturns or rising interest rates, which can negatively impact smaller companies and consumer-focused sectors. Regulatory changes or shifts in market sentiment toward small-cap stocks could also influence its performance.
XSMO Top 10 Holdings
XSMO is leaning hard into U.S. small-cap momentum, with a noticeable tilt toward tech and health care names that are either sprinting ahead or catching their breath. High-flyers like ACM Research, FormFactor, and Protagonist Therapeutics are doing most of the heavy lifting, giving the fund its growthy, innovation-driven feel. On the flip side, ViaSat and Mercury Systems have been losing a bit of altitude lately, while financial player StoneX looks more mixed. Overall, the ETF is concentrated in niche, fast-moving U.S. small caps rather than household names.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ViaSat | 4.02% | $116.49M | $10.33B | 151.64% | 56 Neutral | |
| Formfactor | 3.13% | $90.57M | $9.84B | 239.74% | 68 Neutral | |
| Protagonist Therapeutics | 2.75% | $79.69M | $9.39B | 122.98% | 68 Neutral | |
| Victoria's Secret | 2.60% | $75.13M | $6.69B | 226.27% | 71 Outperform | |
| Madison Square Garden Sports | 2.13% | $61.77M | $9.55B | 83.69% | 45 Neutral | |
| Liquidia Technologies | 1.99% | $57.50M | $6.14B | 205.75% | 57 Neutral | |
| Maxlinear | 1.97% | $57.17M | $7.93B | 428.92% | 60 Neutral | |
| Ligand Pharma | 1.90% | $55.01M | $5.95B | 74.92% | 60 Neutral | |
| Glaukos | 1.74% | $50.48M | $9.43B | 88.76% | 61 Neutral | |
| Plexus | 1.71% | $49.57M | $7.02B | 81.18% | 75 Outperform |
XSMO Technical Analysis
Negative
―
Price Trends
85.90
Negative
86.91
Negative
82.17
Negative
Market Momentum
-1.17
Negative
38.37
Neutral
39.00
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For XSMO, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 83.31, equal to the 50-day MA of 85.90, and equal to the 200-day MA of 82.17, indicating a bearish trend. The MACD of -1.17 indicates Negative momentum. The RSI at 38.37 is Neutral, neither overbought nor oversold. The STOCH value of 39.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for XSMO.
XSMO Peer Comparison
Comparison Results
Performance Comparison
XSMO
Invesco S&P SmallCap Momentum ETF
82.10
10.17
14.14%
FNDA
Schwab Fundamental US Small Co. Index ETF
―
―
―
FESM
Fidelity Enhanced Small Cap ETF
―
―
―
SMLF
iShares MSCI USA Small-Cap Multifactor ETF
―
―
―
VIOO
Vanguard S&P Small-Cap 600 ETF
―
―
―
CALF
Pacer US Small Cap Cash Cows 100 ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents